| Ytd | 8.57% | |
| 1y | 21.02% |
| Open | 41.99 | Prev Close | 41.64 | Low | 41.68 | High | 43.18 | Mkt Cap | 2.18B |
| Vol | 0.00 | Avg Vol | 923.36K | EPS | 0.03 | P/E | 1333.85 | Forward P/E | 96.39 |
| Beta | 1.23 | Short Ratio | 4.62 | Inst. Own | 103.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-23 | 50-d Avg | 32.43 | 200-d Avg | 33.23 | 1yr Est | 47.33 |
This disposition involved 3,500 shares at $38.42 per share, totaling $134,470. The transaction reduc
Karen Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on Aug
On July 31, 2026, AtriCure Inc (ATRC) shares fell 6.0% today, bringing the current price to $37.76.
RSI warning: 3 overbought health care stocks could be flashing a real warning to investors with high
UBS analyst Priya Sachdeva maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price targe
AtriCure, Inc. (ATRC) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the q
AtriCure (ATRC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Est
AtriCure NASDAQ: ATRC reported double-digit revenue growth and a return to GAAP profitability in the
AtriCure (NASDAQ:ATRC) reported second-quarter financial results on Thursday. The transcript from th
AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.18 per share which beat the analyst consens
AtriCure (NASDAQ:ATRC) raises FY2026 Adj EPS guidance from $0.00-$0.04 to $0.24-$0.32 vs $0.06 analy
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatme
Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quar
[url="]AtriCure, Inc.[/url] ([url="]Nasdaq: ATRC[/url]), a leading innovator in surgical treatments
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatme
AtriCure (ATRC) witnessed a jump in share price last session on above-average trading volume. The la
Investors need to pay close attention to ATRC stock based on the movements in the options market lat
AtriCure, Inc. (ATRC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc
[url="]AtriCure, Inc.[/url] ([url="]Nasdaq: ATRC[/url]), a leading innovator in surgical treatments
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatme
AtriCure, Inc. (ATRC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
AtriCure NASDAQ: ATRC executives said the company's 2026 revenue outlook is being supported by recen
Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and raises
AtriCure, Inc. (ATRC) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the q
AtriCure (ATRC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate
2026 Financial GuidanceFull year 2026 revenue is projected to be approximately $600 million to $610
AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.00 per share which beat the analyst consens
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • Unilever (NYSE:UL) is expected to report earnings for its fir
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f
Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo
During Thursday, 849 stocks hit new 52-week lows.
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report qu